Zacks Research Has Bearish Estimate for Exelon Q3 Earnings

Exelon Co. (NASDAQ:EXC) – Research analysts at Zacks Research cut their Q3 2024 earnings estimates for shares of Exelon in a note issued to investors on Tuesday, October 29th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $0.67 per share for the quarter, down from their prior estimate of $0.68. The consensus estimate for Exelon’s current full-year earnings is $2.44 per share. Zacks Research also issued estimates for Exelon’s Q4 2024 earnings at $0.61 EPS, FY2024 earnings at $2.43 EPS, Q2 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.64 EPS, FY2025 earnings at $2.60 EPS, Q1 2026 earnings at $0.77 EPS, Q3 2026 earnings at $0.82 EPS and FY2026 earnings at $2.76 EPS.

Exelon (NASDAQ:EXC) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.71 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.04. Exelon had a return on equity of 9.40% and a net margin of 10.65%. The business had revenue of $6.15 billion during the quarter, compared to analysts’ expectations of $5.85 billion. During the same period in the previous year, the firm earned $0.67 earnings per share. The firm’s quarterly revenue was up 2.9% compared to the same quarter last year.

A number of other research analysts have also recently issued reports on EXC. UBS Group boosted their price objective on shares of Exelon from $40.00 to $43.00 and gave the company a “neutral” rating in a report on Friday, September 20th. Scotiabank upped their price objective on shares of Exelon from $37.00 to $40.00 and gave the company a “sector perform” rating in a research report on Tuesday, August 20th. Jefferies Financial Group assumed coverage on Exelon in a report on Thursday, September 19th. They set a “buy” rating and a $46.00 target price on the stock. Wells Fargo & Company boosted their target price on Exelon from $40.00 to $42.00 and gave the company an “equal weight” rating in a research note on Friday, August 2nd. Finally, Barclays raised their price target on Exelon from $41.00 to $44.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 15th. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Exelon presently has a consensus rating of “Hold” and an average target price of $41.33.

Exelon Stock Performance

Shares of EXC stock opened at $39.30 on Wednesday. The stock has a market cap of $39.32 billion, a PE ratio of 16.17, a price-to-earnings-growth ratio of 2.90 and a beta of 0.53. The stock has a 50-day moving average of $39.65 and a 200-day moving average of $37.70. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.03 and a quick ratio of 0.93. Exelon has a one year low of $33.35 and a one year high of $41.48.

Exelon Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Monday, November 11th will be given a dividend of $0.38 per share. The ex-dividend date of this dividend is Friday, November 8th. This represents a $1.52 annualized dividend and a yield of 3.87%. Exelon’s dividend payout ratio (DPR) is presently 62.55%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of EXC. Crewe Advisors LLC bought a new stake in Exelon in the 1st quarter valued at $26,000. American National Bank & Trust lifted its stake in shares of Exelon by 178.8% during the 3rd quarter. American National Bank & Trust now owns 697 shares of the company’s stock worth $28,000 after buying an additional 447 shares during the last quarter. Versant Capital Management Inc boosted its holdings in shares of Exelon by 646.2% during the 2nd quarter. Versant Capital Management Inc now owns 776 shares of the company’s stock worth $27,000 after buying an additional 672 shares during the period. J.Safra Asset Management Corp bought a new stake in shares of Exelon during the 2nd quarter worth about $28,000. Finally, Abound Wealth Management grew its stake in Exelon by 502.7% in the 2nd quarter. Abound Wealth Management now owns 892 shares of the company’s stock valued at $31,000 after buying an additional 744 shares during the last quarter. 80.92% of the stock is owned by institutional investors and hedge funds.

About Exelon

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.